IDEXX Laboratories Inc
NASDAQGS:IDXX
United States / Healthcare / Healthcare Equipment & Supplies
Exchange Data
Hide this widget
Price
417.71 USD
Day change
0.05 (0.01%)
52-week range
398.50 - 548.88
3:59 p.m. - Closed
Pre Market417.71 +0.00 (+0.00%)
Summary of IDEXX Laboratories Inc
Hide this widget
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
Data could not be retrieved
Data Explorer
Hide this widget
Search metric that you want to observe. Create your own widget, customise and rearrange metrics
| Metric Name | Value | Trend |
|---|---|---|
| Dividend Yield | 0.0% | |
| P/E Ratio | 38.1x | |
| Revenue | 3.898 B | |
| Net Income to Company | - |
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| IDXX | Peers | Sector | |
|---|---|---|---|
Market Cap | 33.851 B | 62.095 M | 65.396 M |
Price % of 52 Week High | Premium | 64.5% | 62.3% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | Premium | -3.7% | -0.7% |
1 Year Price Total Return | -22.6% | -8.0% | -11.0% |
Beta (5 Year) | 1.39 | 1.08 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for IDEXX Labs is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Financial Models for IDEXX Laboratories Inc
Model Gallery
Hide this widget
| 10Y DCF EBITDA ExitView Updated 10 hours ago |
| 10Y DCF Revenue ExitView Updated 10 hours ago |
| 10Y DCF Growth ExitView Updated 10 hours ago |
| 5Y DCF EBITDA ExitView Updated 10 hours ago |
| 5Y DCF Revenue ExitView Updated 10 hours ago |
| 5Y DCF Growth ExitView Updated 10 hours ago |
| DuPont ROE AnalysisView Updated 1 day ago |
| 10Y Historical FinancialsView Updated 1 day ago |
| 5Y Historical FinancialsView Updated 1 day ago |
| EV / EBIT MultiplesView Updated 10 hours ago |
| EV / EBITDA MultiplesView Updated 10 hours ago |
| P/E MultiplesView Updated 10 hours ago |
| Price / Book MultiplesView Updated 10 hours ago |
| Price / Sales MultiplesView Updated 10 hours ago |
| EV / Revenue MultiplesView Updated 10 hours ago |
| CAPM WACC ModelView Updated 16 hours ago |
| Earnings Power ValueView Updated 10 hours ago |
Historical Financials
Full Financials
Hide this widget
| (USD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 3,367 | 3,661 | 3,898 | 902 | 954 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | |||||
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 1,470 | 1,067 | 987 | 1,067 | 987 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | 394 | 773 | 808 | 217 | 233 |
Analyst Notes
March 27, 2025
Hide this widget